US FDA Doesn’t Need Conditional Approval Pathway, Cavazzoni Tells House Committee

CDER Director Patrizia Cavazzoni answers questions virtually on drug development in neurodegenerative diseases during a House Energy and Commerce Health Subcommittee hearing. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet